Inhibition of voriconazole metabolism by chloramphenicol in an adolescent with central nervous system aspergillosis

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 11, 2008, Pages 4172-4174

  Hafner, Verena ^a   Albermann, Nadine ^b   Haefeli, Walter E ^a   Ebinger, Friedrich ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Neonatology ^*  (Germany)

^c Department of Pediatrics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; MEROPENEM; OMEPRAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RANITIDINE; VANCOMYCIN; VORICONAZOLE;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLOSIS; BACTERIAL MENINGITIS; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG METABOLISM; DRUG WITHDRAWAL; HUMAN; MALE; PRIORITY JOURNAL; SEPTIC SHOCK;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ARYL HYDROCARBON HYDROXYLASES; CHLORAMPHENICOL; CYTOCHROME P-450 CYP3A; DRUG INTERACTIONS; ENZYME INHIBITORS; HUMANS; LIVER; MALE; NEUROASPERGILLOSIS; PYRIMIDINES; TRIAZOLES;

EID: 55849096952     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00805-08     Document Type: Article

References (22)

1. Ciaccio, P. J., D. B. Duignan, and J. R. Halpert. 1987. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozymes of dog liver cytochrome P-450. Drug Metab. Dispos. 15:852-856.
2. Falagas, M. E., and P. Kopterides. 2007. Old antibiotics for infections in critically ill patients. Curr. Opin. Crit. Care 13:592-597.
3. Halpert, J., C. Balfour, N. E. Miller, E. T. Morgan, D. Dunbar, and L. S. Kaminsky. 1985. Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo. Mol. Pharmacol. 28:290-296.
4. Herbrecht, R., D. W. Denning, T. F. Patterson, J. E. Bennett, R. E. Greene, J. W. Oestmann, W. V. Kern, K. A. Marr, P. Ribaud, O. Lortholary, R. Sylvester, R. H. Rubin, J. R. Wingard, P. Stark, C. Durand, D. Caillot, E. Thiel, P. H. Chandrasekar, M. R. Hodges, H. T. Schlamm, P. F. Troke, and B. de Pauw. 2002. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 347:408-415.
5. Hyland, R., B. C. Jones, and D. A. Smith. 2003. Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole. Drug Metab. Dispos. 31:540-547.
6. Koup, J. R., M. Gibaldi, P. McNamara, D. M. Hilligoss, W. A. Colburn, and E. Bruck. 1978. Interaction of chloramphenicol with phenytoin and phenobarbital. Clin. Pharmacol. Ther. 24:571-575.
7. Mathis, A. S., N. Shah, G. T. Knipp, and G. S. Friedman. 2002. Interaction of chloramphenicol and the calcineurin inhibitors in renal transplant recipients. Transpl. Infect. Dis. 4:169-174.
8. Ogutu, B. R., C. R. Newton, S. N. Muchohi, G. O. Otieno, and G. O. Kokwaro. 2002. Phenytoin pharmacokinetics and clinical effects in African children following fosphenytoin and chloramphenicol coadministration. Br. J. Clin. Pharmacol. 54:635-642.
9. Park, J. Y., K. A. Kim, and S. L. Kim. 2003. Chloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomes. Antimicrob. Agents Chemother. 47:3464-3469.
10. Pasqualotto, A. C., M. Shah, R. Wynn, and D. W. Denning. 2008. Voriconazole plasma monitoring. Arch. Dis. Child. 93:578-581.
11. 2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole. Br. J. Clin. Pharmacol. 56:51-55.
12. Rengelshausen, J., M. Banfield, K.-D. Riedel, J. Burhenne, J. Weiss, T. Thomsen, I. Walter-Sack, W. E. Haefeli, and G. Mikus. 2005. Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics. Clin. Pharmacol. Ther. 78:25-33.
13. Rivory, L. P., H. Qin, S. J. Clarke, J. Eris, G. Duggin, E. Ray, R. J. Trent, and J. F. Bishop. 2000. Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance. Eur. J. Clin. Pharmacol. 56:395-398.
14. Schulman, S. L., L. M. Shaw, K. Jabs, M. B. Leonard, and K. L. Brayman. 1998. Interaction between tacrolimus and chloramphenicol in a renal transplant recipient. Transplantation 65:1397-1398.
15. Singh, N., A. P. Limaye, G. Forrest, N. Safdar, P. Muñoz, K. Pursell, S. Houston, F. Rosso, J. G. Montoya, P. Patton, R. Del Busto, J. M. Aguado, R. A. Fisher, G. B. Klintmalm, R. Miller, M. M. Wagener, R. E. Lewis, D. P. Kontoyiannis, and S. Husain. 2006. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation 81:320-326.
16. Smith, J., N. Safdar, V. Knasinski, W. Simmons, S. M. Bhavnani, P. G. Ambrose, and D. Andes. 2006. Voriconazole therapeutic drug monitoring. Antimicrob. Agents Chemother. 50:1570-1572.
17. Stiefel, M., T. Reiss, M. S. Staege, J. Rengelshausen, J. Burhenne, A. Wawer, and J. L. Foell. 2005. Successful treatment with voriconazole of aspergillus brain abscess in a boy with medulloblastoma. Pediatr. Blood Cancer 49:203-207.
18. Taber, D. J., R. E. Dupuis, K. D. Hollar, A. L. Strzalka, and M. W. Johnson. 2000. Drug-drug interaction between chloramphenicol and tacrolimus in a liver transplant recipient. Transplant. Proc. 32:660-662.
19. Walsh, T. J., I. Lutsar, T. Driscoll, B. Dupont, M. Roden, P. Ghahramani, M. Hodges, A. H. Groll, and J. R. Perfect. 2002. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr. Infect. Dis. J. 21:240-248.
20. Walsh, T. J., M. O. Karlsson, T. Driscoll, A. G. Arguedas, P. Adamson, X. Saez-Llorens, A. J. Vora, A. C. Arrieta, J. Blumer, I. Lutsar, P. Milligan, and N. Wood. 2004. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob. Agents Chemother. 48:2166-2172.
21. Wood, N., K. Tan, L. Purkins, G. Layton, J. Hamlin, D. Kleinermans, and D. Nichols. 2003. Effect of omeprazole on the steady-state pharmacokinetics of voriconazole. Br. J. Clin. Pharmacol. 56:56-61.
22. Yacobi, A., C. M. Lai, and G. Levy. 1984. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats. J. Pharmacol. Exp. Ther. 231:80-84.